-+ 0.00%
-+ 0.00%
-+ 0.00%

Adial Pharmaceuticals Plans To Change Corporate Name To Azora Therapeutics, Nasdaq Ticker to AZR, Effective Oct. 29

Benzinga·10/28/2026 20:21:41
Listen to the news

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company developing treatments for serious inflammatory diseases, today announced that it has changed its corporate name to Azora Therapeutics, Inc. The company’s common stock is expected to commence trading on The Nasdaq Capital Market under the new ticker symbol "AZR" on October 29, 2026.